MassMutual Private Wealth & Trust
AXDX icon

MassMutual Private Wealth & Trust’s Accelerate Diagnostics AXDX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-137
Closed -$2K – 1510
2022
Q1 		$2K Buy
+137
New +$3.9K ﹤0.01% 1121

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Belpointe Asset Management
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

MassMutual Private Wealth & Trust's AXDX Position: Q2 2022 in Review

MassMutual Private Wealth & Trust sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 137 shares — an estimated $2K sold.

MassMutual Private Wealth & Trust first reported a position in AXDX in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • MassMutual Private Wealth & Trust reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 137 Accelerate Diagnostics shares in Q2 2022, an estimated $2K.
  • MassMutual Private Wealth & Trust first reported a position in Accelerate Diagnostics in Q1 2022 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's Accelerate Diagnostics position peaked at $2K in Q1 2022.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2022, filed 7 Jul 2022.